ASCT2-targeted GluB delivery strategy for BNCT (IMAGE)
Caption
Researchers designed glutamate-mimicking boron carriers that use ASCT2 instead of LAT1, enabling boron accumulation in BPA-resistant tumors and potentially widening eligibility for the BNCT.
Credit
Institute of Science Tokyo
Usage Restrictions
For use in scientific news only. Attribution is required. The image may not be modified in ways that alter its meaning or context.
License
Original content